Recap: Collegium Pharmaceutical Q4 Earnings - Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical COLL reported its Q4 earnings results on Thursday, February 22, 2024 at 04:10 PM.

Here's what investors need to know about the announcement.

Collegium Pharmaceutical beat estimated earnings by 139.39%, reporting an EPS of $1.58 versus an estimate of $0.66.

Revenue was up $20.12 million from the same period last year.

Last quarter the company beat on EPS by $0.82 which was followed by a 6.6% increase in the share price the next day.

Here's a look at Collegium Pharmaceutical's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	0.52	1.22	0.31	-0.14
EPS Actual	1.34	1.26	1.32	1.09
Revenue Estimate	138.53M	137.98M	138.47M	125.19M
Revenue Actual	136.71M	135.55M	144.77M	129.62M

To track all earnings releases for Collegium Pharmaceutical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.